In this week’s Solidarity Friday episode, Joe Moore, Michelle Janikian, and Kyle Buller talk about the importance of critiquing established systems and the need to include more queer and non-binary people in clinical trials. And they review several news stories: Mexico decriminalizing cannabis, Scott Weiner’s Senate Bill 519 making more progress in California, and Connecticut becoming the 18th state to legalize cannabis. They also discuss the Canadian government funding Toronto-based Braxia Scientific in a ketamine trial for bipolar depression, and more!

The post PTSF66 – Philosophical Critiques, Legalization Updates, and Inclusive Research appeared first on Psychedelics Today.

Previous articlePsilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional Investors to Accelerate Clinical Pipeline Focused on DMT
Next articlePsychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill Clears Latest Hurdle; LSD for Food Allergies?